Friday Evening Mini symposium
at 2026 ASBrS meeting

Seattle Convention Center

Room number 6B

May 1st 2026 7:00 PM to 8:45 PM (Registration and dinner start at 6:45 PM.)

Topic: Genomic Testing for Managing Atypical Hyperplasia Patients

SCROLL DOWN TO REGISTER FOR WEBINAR

Silbiotech, Inc. will host a dinner symposium on managing atypical hyperplasia patients using genomic test, BBDRisk Dx, for personalized clinical decision-making. The test is approved for coverage by Medicare, Medicare Advantage Plans, Medicaid of several States, UnitedHealthCare, Cigna, Anthem BCBS, Federal BCBS, BCBS of most States and several other commercial insurance agencies. The clinical study, test development, validation and publications will be presented. Data on several Case Reports will also be presented. Audience will have an opportunity to ask questions.

Topics to Be Discussed

  • Breast Cancer Rates among Atypical Hyperplasia Patients
  • Genomic Test for Personalized Risk Assessment
  • Genomic Information for Informed Management

Presenter

Indira Poola, Ph.D
Scientist, Silbiotech, Inc.,
Former Professor of Biochemistry
and Molecular Biology and Surgery


This symposium/program is supported by Silbiotech, Inc through a marketing grant. It is not part of the official American Society of Breast Surgeons annual meeting program, and no AMA PRA Category 1 Credits™ have been assigned to them by the ASBrS.